These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Pharmacotherapeutic environments for substance use disorders. Gardner TJ; Kosten TR Am J Drug Alcohol Abuse; 2007; 33(5):627-9. PubMed ID: 17891655 [No Abstract] [Full Text] [Related]
23. Detoxification considerations in the medical management of substance abuse in pregnancy. Allen MH Bull N Y Acad Med; 1991; 67(3):270-6. PubMed ID: 1868278 [No Abstract] [Full Text] [Related]
24. Methadone and opiate addiction again. N Z Med J; 1973 May; 77(492):330-1. PubMed ID: 4516090 [No Abstract] [Full Text] [Related]
25. Methadone treatment and rehabilitation service. Shanholtz MI Va Med Mon (1918); 1973 Oct; 100(10):956-8. PubMed ID: 4747466 [No Abstract] [Full Text] [Related]
26. Overview: protracted effects of early exposure to drugs of abuse. Sonderegger T; Zimmermann E Pharmacol Biochem Behav; 1979; 11 Suppl():1-2. PubMed ID: 121598 [No Abstract] [Full Text] [Related]
27. Opiate-dependent patients receiving methadone. How physicians should manage therapy. Kahan M; Sutton N Can Fam Physician; 1996 Sep; 42():1769-78. PubMed ID: 8828879 [TBL] [Abstract][Full Text] [Related]
28. A randomized, open-label trial comparing methadone and Levo-Alpha-Acetylmethadol (LAAM) in maintenance treatment of opioid addiction. Wolstein J; Gastpar M; Finkbeiner T; Heinrich C; Heitkamp R; Poehlke T; Scherbaum N Pharmacopsychiatry; 2009 Jan; 42(1):1-8. PubMed ID: 19153939 [TBL] [Abstract][Full Text] [Related]
29. Methadone maintenance in pregnancy: consequences to care and outcome. Edelin KC; Gurganious L; Golar K; Oellerich D; Kyei-Aboagye K; Adel Hamid M Obstet Gynecol; 1988 Mar; 71(3 Pt 1):399-404. PubMed ID: 3347426 [TBL] [Abstract][Full Text] [Related]
30. Abstinence-based incentives in methadone maintenance: interaction with intake stimulant test results. Stitzer ML; Peirce J; Petry NM; Kirby K; Roll J; Krasnansky J; Cohen A; Blaine J; Vandrey R; Kolodner K; Li R Exp Clin Psychopharmacol; 2007 Aug; 15(4):344-50. PubMed ID: 17696681 [TBL] [Abstract][Full Text] [Related]
31. Program monitoring for clinical practice. Specimen positivity across urine collection methods. Moran J; Mayberry C; Kinniburgh D; James D J Subst Abuse Treat; 1995; 12(3):223-6. PubMed ID: 7474030 [TBL] [Abstract][Full Text] [Related]
32. Management of cocaine abuse in methadone maintenance programs. Kolar AF Md Med J; 1989 Dec; 38(12):1067-8. PubMed ID: 2615578 [No Abstract] [Full Text] [Related]
33. NIDA's Medication Development Program--1989. Schuster CR; Snyder M NIDA Res Monogr; 1989; 95():64-73. PubMed ID: 2641056 [No Abstract] [Full Text] [Related]
34. [Results of urinary control analyses of narcotic addicts on methadone therapy. An evaluation in the county of ]rhus in 1993]. Olesen OV; Linnet K; Rosenberg R Ugeskr Laeger; 1995 Feb; 157(6):719-23. PubMed ID: 7701629 [TBL] [Abstract][Full Text] [Related]
35. The use of drugs in the management of drug dependence. Eddy NB J Tenn Med Assoc; 1967 Mar; 60(3):269-73. PubMed ID: 6042204 [No Abstract] [Full Text] [Related]
36. Novel pharmacotherapeutic approaches for the treatment of drug addiction and craving. Heidbreder CA; Hagan JJ Curr Opin Pharmacol; 2005 Feb; 5(1):107-18. PubMed ID: 15661634 [TBL] [Abstract][Full Text] [Related]
37. [Better understanding of methadone]. Ouellet JM Perspect Infirm; 2005; 2(3):42-3. PubMed ID: 15686212 [No Abstract] [Full Text] [Related]
38. Management of drug dependence. Mitcheson M Practitioner; 1983 Jan; 227(1375):127-37. PubMed ID: 6844227 [No Abstract] [Full Text] [Related]
39. Methadone replacement therapy. Brownlie JM N Z Med J; 1972 May; 75(480):312-3. PubMed ID: 4503628 [No Abstract] [Full Text] [Related]
40. [The official methadone politic. Some critical comments]. Freitag P Ugeskr Laeger; 1978 Dec; 140(50):3169-71. PubMed ID: 726133 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]